I’m reaching out to share that Kirkland-based EvergreenHealth, the hospital with the nation’s first recorded patient death due to COVID-19 back in February, has launched a new clinical trial to study an antibody therapy as a potential treatment for the virus.
The BLAZE - 1 Study is designed to look at the safety and efficacy of treating adults who have recently tested positive for COVID-19, and who are not hospitalized, with the investigational study drug, LY-Co-V555. EvergreenHealth is the only health system in Washington state to serve as a trial site for the BLAZE-1 Study.
-- EvergreenHealth Press Release, 9/15/2020
No comments:
Post a Comment
COMMENT HERE - COMMENTS ARE MODERATED